Insider Activity of Secora Michael
Biography of Secora Michael
No biography is available at this moment.
No biography is available at this moment.
| 2024-11-13 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0055% | $7.66 | $114,876 | -22.27% | |
| 2024-11-12 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0055% | $7.64 | $114,629 | -24.8% | |
| 2024-10-09 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0047% | $6.36 | $95,375 | -5.28% | |
| 2024-10-08 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0047% | $6.32 | $94,757 | -9.55% | |
| 2024-09-11 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0054% | $6.32 | $94,730 | -4.5% | |
| 2024-09-10 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0053% | $6.17 | $92,499 | -2.37% | |
| 2024-08-14 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0057% | $6.35 | $95,252 | +0.72% | |
| 2024-08-13 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0057% | $6.35 | $95,183 | -3.29% | |
| 2024-07-10 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0054% | $7.24 | $108,576 | -9.47% | |
| 2024-07-09 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0054% | $7.32 | $109,778 | -11.83% | |
| 2024-06-14 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.007% | $9.27 | $139,082 | -27.86% | |
| 2024-06-13 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 15,000 0.0071% | $9.32 | $139,799 | -29.18% | |
| 2024-04-17 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 23,124 0.0109% | $7.58 | $175,349 | -4.15% | |
| 2024-04-16 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0117% | $7.67 | $191,658 | -5.42% | |
| 2024-03-13 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0117% | $11.03 | $275,815 | -32.29% | |
| 2024-03-12 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0115% | $10.46 | $261,375 | -29.41% | |
| 2024-02-14 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0111% | $10.46 | $261,425 | -31.04% | |
| 2024-02-13 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0104% | $9.86 | $246,560 | -23.16% | |
| 2024-01-17 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0116% | $10.25 | $256,348 | -25.05% | |
| 2024-01-16 | Sale | Recursion Pharmaceuticals, Inc. RXRX | Chief Financial Officer | 25,000 0.0112% | $10.45 | $261,160 | -28.02% |